LCLT is used as nutritional therapy in the treatment of fatty liver and hemorrhagic shock in pharmaceutical and as a nutritional supplement in agriculture/animal feed to increase the growth rate and reduce the fat rate of aquatic animal
The product combines BPC-157, a synthetic pentadecapeptide analysed in models related to fibroblasts, angiogenesis and tissue response, and TB-500, a peptide linked to the active regions of thymosin beta-4, reported in the literature in the context of the actin cytoskeleton, cell migration and tissue remodelling
These findings are summarised in Figure 1 below and highlight the broad therapeutic potential of GLP-1s across multiple disease areas
One cost advantage of PTD-DBM is that it does not require ongoing clinical visits
A study conducted on cyclists showed that a 7-day consumption of nano-bubble hydrogen-rich water improved the anaerobic performance of trained cyclists compared to that of untrained ones
A Phase 1 data showed that weekly injections of VK2735 led to mean body weight decrease ranging up to 6% over placebo